HOXC8 and breast carcinoma: Further exploring its clinical relevance, it was found that the high expression of HOXC8 and CDH11 was related to the low recurrence free survival rate of breast cancer patients, which further indicated that targeting the HOXC8-CDH11 signal axis was a direction of developing anti metastasis therapy for breast cancer 34,35.